cro.directory
← Compare landing

PSI vs Sharp Services

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryPSISharp Services
SummaryPSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases.Specialist CDMO offering sterile injectable manufacturing with 100% isolator-based fills, clinical trial services, and commercial packaging for autoinjectors and pre-filled syringes. Operates a network of GMP facilities across the US, UK, and EU.
Services
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
Data not yet provided.
Modalities
  • Cell Therapy
  • Gene Therapy
  • Radiopharmaceutical
  • Gene Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Respiratory
  • Gastroenterology
  • Nephrology
Data not yet provided.
Phases
  • Phase II
  • Phase III
Data not yet provided.
Sourcing models
  • Full-Service Outsourcing (FSO)
Data not yet provided.
Locations
  • Osaka, Osaka, Osaka, Japan
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.

Find similar companies

PSI alternatives · Sharp Services alternatives

Markdown mirror: /compare/appian/sharpservices.md